These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 21444357)
1. Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG). Garbay D; Le Cesne A; Penel N; Chevreau C; Marec-Berard P; Blay JY; Debled M; Isambert N; Thyss A; Bompas E; Collard O; Salas S; Coindre JM; Bui B; Italiano A Ann Oncol; 2012 Jan; 23(1):182-186. PubMed ID: 21444357 [TBL] [Abstract][Full Text] [Related]
2. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study. Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699 [TBL] [Abstract][Full Text] [Related]
3. [Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors]. Fan Z; Li S; Fang Z; Liu J; Bai C; Xue R; Zhang L; Gao T Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):39-43. PubMed ID: 26806736 [TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis. Park KH; Choi YJ; Kim KW; Ro KH; Kang CH; Song SH; Park JH Jpn J Clin Oncol; 2016 Sep; 46(9):845-9. PubMed ID: 27365524 [TBL] [Abstract][Full Text] [Related]
5. Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial. Nishida Y; Hamada S; Urakawa H; Ikuta K; Sakai T; Koike H; Ito K; Emoto R; Ando Y; Matsui S Cancer Sci; 2020 Nov; 111(11):4187-4194. PubMed ID: 32816351 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). de Camargo VP; Keohan ML; D'Adamo DR; Antonescu CR; Brennan MF; Singer S; Ahn LS; Maki RG Cancer; 2010 May; 116(9):2258-65. PubMed ID: 20187095 [TBL] [Abstract][Full Text] [Related]
7. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis. Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293 [TBL] [Abstract][Full Text] [Related]
8. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI. Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review. Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730 [TBL] [Abstract][Full Text] [Related]
10. Therapy of desmoid tumors and fibromatosis using vinorelbine. Weiss AJ; Horowitz S; Lackman RD Am J Clin Oncol; 1999 Apr; 22(2):193-5. PubMed ID: 10199460 [TBL] [Abstract][Full Text] [Related]
12. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE; J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study. Skapek SX; Anderson JR; Hill DA; Henry D; Spunt SL; Meyer W; Kao S; Hoffer FA; Grier HE; Hawkins DS; Raney RB Pediatr Blood Cancer; 2013 Jul; 60(7):1108-12. PubMed ID: 23281268 [TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. Skapek SX; Hawk BJ; Hoffer FA; Dahl GV; Granowetter L; Gebhardt MC; Ferguson WS; Grier HE J Clin Oncol; 1998 Sep; 16(9):3021-7. PubMed ID: 9738571 [TBL] [Abstract][Full Text] [Related]
15. Oral vinorelbine in young patients with desmoid-type fibromatosis. Kornreich L; Orbach D; Nicolas N; Brisse HJ; Berlanga P; Defachelles AS; Mansuy L; Verite C; Saumet L; Karanian M; Corradini N Tumori; 2023 Oct; 109(5):511-518. PubMed ID: 37114926 [TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy in fibromatoses of childhood and adolescence: results from the Cooperative soft tissue sarcoma study (CWS) and the Italian Cooperative study group (ICG-AIEOP)]. Pilz T; Pilgrim TB; Bisogno G; Knietig R; Koscielniak E; Carli M; Treuner J Klin Padiatr; 1999; 211(4):291-5. PubMed ID: 10472564 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India. Bajpai J; Munot P; Kota K; Gupta G; Gala K; Gulia A; Rekhi B; Khanna N; Shetty N; Bhargava P; Srinivas S; Ostwal V; Patil V; Noronha V; Kulkarni S; Laskar S; Prabhash K; Chinnaswamy G; Gupta S; Banavali S JCO Glob Oncol; 2024 May; 10():e2300308. PubMed ID: 38723218 [TBL] [Abstract][Full Text] [Related]
18. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Azzarelli A; Gronchi A; Bertulli R; Tesoro JD; Baratti D; Pennacchioli E; Dileo P; Rasponi A; Ferrari A; Pilotti S; Casali PG Cancer; 2001 Sep; 92(5):1259-64. PubMed ID: 11571741 [TBL] [Abstract][Full Text] [Related]
19. Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series. Frezza AM; Jones RL; Lo Vullo S; Asano N; Lucibello F; Ben-Ami E; Ratan R; Teterycz P; Boye K; Brahmi M; Palmerini E; Fedenko A; Vincenzi B; Brunello A; Desar IME; Benjamin RS; Blay JY; Broto JM; Casali PG; Gelderblom H; Grignani G; Gronchi A; Hall KS; Mir O; Rutkowski P; Wagner AJ; Anurova O; Collini P; Dei Tos AP; Flucke U; Hornick JL; Lobmaier I; Philippe T; Picci P; Ranchere D; Renne SL; Sbaraglia M; Thway K; Wagrodzki M; Wang WL; Yoshida A; Mariani L; Kawai A; Stacchiotti S JAMA Oncol; 2018 Sep; 4(9):e180219. PubMed ID: 29800950 [TBL] [Abstract][Full Text] [Related]
20. Advanced aggressive fibromatosis: Effective palliation with chemotherapy. Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I Acta Oncol; 2011 Apr; 50(3):455-61. PubMed ID: 20799916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]